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Abstract
Introduction
The Baby Hearts study aimed to investigate risk and protective factors for congenital heart disease
(CHD), and to investigate the health behaviours of a representative sample of pregnant women in
Northern Ireland.
Objectives
We describe and evaluate the population-based case-control design enhanced with data linkage to
administrative health data.
Methods
Cases (mothers of babies with CHD, n=286) were recruited following diagnosis prenatally or post-
natally. Controls (mothers of babies without CHD, n=966) were recruited at 18-22 weeks gestation,
from all women attending each maternity unit during a designated month. Hybrid data collection
methods were used, including a self-administered iPad/postal questionnaire, and linkage to maternity
and prescription records.
Results
Refusal rates were low (8%). iPad questionnaire completion at clinic or home visit had high accept-
ability whereas postal questionnaires were poorly returned leading to a further 9-10% loss of eligible
cases/controls. In total, 61% of eligible cases and 68% of eligible controls were recruited, closely
representative of the Northern Ireland population, with no evidence of selection bias. Of those re-
cruited, 97% gave consent for linkage to medical records. Thirty-three percent of women had an
unplanned pregnancy and 76% suspected they were pregnant by 5 weeks gestation, with no signifi-
cant differences between cases and controls. There was considerable discordance between self-report,
maternity and prescription records regarding medications obtained/taken in the first trimester, but
no evidence of differences between cases and controls that would indicate substantial recall bias.
Although there was high concordance between self-report and maternity records regarding folic acid
supplementation, cases had significantly lower concordance than controls.
Conclusions
Our results suggest hybrid data collection approaches are a useful way forward for aetiological studies
to reduce responder burden and address and estimate recall bias, and that the Baby Hearts study
protocol is suitable for replication in other populations, modified to the local context.
Introduction
Congenital heart disease (CHD) accounts for nearly one third
of babies with major congenital anomalies diagnosed prena-
tally or in infancy in Europe, with an average prevalence of 8
per 1,000 births, varying between countries [1]. Whilst there
have been significant advances in identifying the role of genetic
factors, slow progress has been made recently in understand-
ing environmental risk factors for CHD [2,3]. Previous large
case-control studies have included the Baltimore-Washington
Infants Study [4] and the United States National Birth De-
fects Prevention Study [5], but no large aetiological studies
have been published from Europe. New methods of data
collection have meanwhile become available for case-control
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studies, including linkage to health records, to increase their
cost-effectiveness and potentially tackle sources of bias [6].
The aim of the Baby Hearts study was to investigate en-
vironmental risk and protective factors for CHD. The case-
control study was conducted in Northern Ireland and focused
particularly on common exposures where there is scientific un-
certainty about their relationship to CHD risk, including peri-
conceptional folic acid [7,8], maternal smoking [9,10], mater-
nal obesity [11,12], and maternal depression and use of an-
tidepressants [13,14]. Primary data collection from women,
enabled by iPad questionnaires, is enhanced by linkage to
electronic healthcare records (prescription data and maternity
data) and area-based deprivation data. A secondary aim was
to investigate the health behaviours of a representative sample
of pregnant women (the control population) in the periconcep-
tional period.
In this paper, we describe and evaluate the design and
methodology of the Baby Hearts Study using hybrid data col-
lection methods. We assess the feasibility of recruiting cases
and an unbiased population sample of cases and controls; the
acceptability, advantages and limitations of data collection
from mothers via iPad questionnaire and potential for recall
bias; and the feasibility and added value of data linkage with
health records to reduce responder burden and reduce recall
bias. We thus propose a protocol which can be reused in fu-
ture (modified to local contexts). We also establish baseline
information on population characteristics and data quality for
the interpretation of the results.
Methods
Design and Setting
A population-based case-control study was conducted. North-
ern Ireland has approximately 24,000 annual births, with ma-
ternity care free to all resident women and paediatric cardi-
ology care delivered by a single specialist centre within the
geographic region. All babies with CHD suspected prenatally
or postnatally are referred to this centre. Termination of preg-
nancy is not legal in Northern Ireland.
Definition of cases and controls and eligibility
criteria.
Cases were babies diagnosed with CHD (prenatally or up to 6
months of age) born to mothers resident in Northern Ireland,
diagnosed by the regional specialist centre and recorded in the
Heartsuite database (a clinical information management sys-
tem used by paediatric cardiology services). A diagnosis of
CHD is made after babies have undergone a range of tests,
including an echocardiogram which is considered as the gold
standard. Stillborn babies with CHD were eligible for inclu-
sion if diagnosis had been made prenatally. All cases of CHD
were further classified by the paediatric cardiologists (FC and
BC), based on diagnostic information extracted from the clini-
cal database, to categories proposed by Houyel and colleagues
[15]. This system groups cases into one of 10 main categories
based on anatomical and clinical criteria.
CHD recruitment excluded patent ductus arteriosus linked
to prematurity, patent foramen ovale, and CHD associated
with Down Syndrome. CHD associated with other genetic
syndromes are to be excluded at data analysis stage. Controls
were babies without CHD with mothers resident in Northern
Ireland at time of recruitment. No other health restrictions
were placed on controls. Cases and controls were included
if their mothers could read and understand English or Polish
(the most frequent language among non-English speakers in
Northern Ireland) and were aged at least 17 years at time of
recruitment.
Identification, Consent and Recruitment of
cases
Cases were identified, consented and recruited from Septem-
ber 2014 to February 2017. Eligible babies with CHD were
identified by clinical staff screening in/outpatient lists and the
clinical database. Mothers of babies with CHD identified pre-
natally were given information by the Fetal Cardiology Nurse,
and if interested were contacted by a researcher, who arranged
to meet at a future hospital appointment. For babies identi-
fied postnatally, information was sent by post informing case
mothers that a researcher would invite them to participate
at their next hospital appointment. For those women whose
babies had less frequent appointments or attended outreach
clinics, the study questionnaire was sent by post, followed by
a phone call. Due to poor response for postal questionnaires,
women were later offered a home visit. Thirteen cases who
were diagnosed after 6 months of age were recruited, where
the defect was severe enough that an earlier diagnosis would
have been expected.
Identification, Consent and Recruitment of
Controls
Controls were identified, consented and recruited during the
period June 2014 to February 2016. Recruitment of con-
trol mothers used a “one month per health unit” intensive
approach, with every eligible woman attending for her first
anomaly scan (at 18-22 weeks gestation) during that month
eligible for recruitment by the researcher. Seventeen health
units performed fetal anomaly scans throughout Northern Ire-
land. This strategy was designed to result in a representative
population sample, and to minimise disruption and simplify
access in maternity units. Posters were displayed within each
unit, stating the designated month for recruitment in that par-
ticular unit. Midwives were asked to hand patient information
leaflets to all women attending for their antenatal booking ap-
pointment between 8-14 weeks gestation so that they would
expect the researcher in the designated month, but during
recruitment, women were also given time to read the informa-
tion leaflets as some women did not remember receiving it or
had moved between units. The patient information leaflet was
developed with the input of clinical staff and patient represen-
tatives, and included positive pictures of children of various
ages with CHD whose mothers had given consent for their
images to be used.
Women completed the questionnaire by iPad before or af-
ter their scan or they could choose to take a paper question-
naire home instead (questionnaires in Polish were only avail-
able on paper) and for two weeks, follow-up reminder calls
were made. Where participants initially took part as a control
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mother, but their baby was subsequently diagnosed with CHD,
mothers were asked for new consent for inclusion of their baby
as a case. As an incentive to participate and token of appreci-
ation, all participants (cases and controls) were offered a gift
token for £10 to be redeemed in a number of online and high
street shops.
Exposure Information
Women were asked to complete a self-report questionnaire,
and to give permission for linkage of these questionnaires to
medical records.
Self-report questionnaire
Topics included sociodemographic information, questions
about when the woman suspected and confirmed she was preg-
nant, folic acid supplementation, diet (focusing on folate rich
foods), maternal smoking and alcohol use, exercise, exposure
to stressful life events, maternal and paternal health condi-
tions, medication use and exposure to a variety of substances
at home and work [Appendix 1]. Sources for questions in-
cluded the Baltimore Washington Infant Study [4], the Na-
tional Birth Defects Prevention Study (NBDPS) [5], the Avon
Longitudinal Study of Parents and Children (ALSPAC) [16],
the Pregnancy Risk Assessment Monitoring System (PRAMS)
studies [17], and a case-control study of gastroschisis [18],
with additional questions formulated by the study team.
Although paternal factors were not the subject of study, a
few questions were included about the father/partner’s health,
to take the focus off the woman in terms of potential guilt.
The periconceptional period of interest was defined as
three months before conception and the first three months (12
weeks) of pregnancy. The preconceptional period is important
to ascertain “normal” behaviours until women find out they
are pregnant, and to allow for the longer acting exposures.
“Postconceptional” was defined as the first three months of
pregnancy.
An iPad application was programmed with touch screen
functionality for data entry and a skip logic function that au-
tomatically hid questions not relevant to the mother (based on
her previous responses). Prompts informing participants of the
number of skipped questions and taking them back to them
were used to reduce the proportion of missing responses. To
facilitate recall, a timeline was created, visible at the bottom
of each page, to show women the calendar dates correspond-
ing to the three months before and after conception. This was
estimated based on their answers to a question regarding their
current gestational age (or for postnatal cases, estimated due
date), combined with the current date. The iPad/tablet had
the additional advantages of confidentiality allowing honesty,
and direct coding of answers.
The questionnaire was designed to be as short as possible
in order to ensure a high response and completion rate. Pi-
lot studies indicated that women preferred completion to take
no longer than 15-20 minutes. Depending on the complexity
of exposures reported by the woman, time taken to complete
ranged from 12 to 25 minutes. The questionnaire and infor-
mation leaflets were reviewed by the study’s external advisory
committee which included a mother of a child with CHD. The
App will be made freely available at completion of the study.
Maternity records
The Northern Ireland Maternity System (NIMATS) is a web
based information system that collects antenatal, intranatal
and postnatal data on all women in receipt of maternity care
in NI. Where women gave their consent, information recorded
at the ‘booking appointment’ at 10-12 weeks was taken from
NIMATS. Information collated included parity, Body Mass In-
dex, date of Last Menstrual Period (LMP), nausea experience,
medication use during pregnancy, pre and post-conceptional
folic acid use, smoking habits and alcohol consumption, dia-
betes and other maternal chronic diseases.
Pharmacy records
Information on prescriptions issued by General Practitioners
and dispensed by pharmacists in Northern Ireland are stored
in the Enhanced Prescribing Database. Information includes
the date the prescription was redeemed, non-proprietary and
proprietary name of the medication, and dosage and quantity
dispensed. We requested an extract of information on all medi-
cations from British National Formulary chapters 2 (Cardiovas-
cular system); 3 (Respiratory system including antiasthmatics
chapters 3:1:1 and 3:2:2), 4 (Central nervous system includ-
ing antidepressants chapters 4:3:3 and 4:3:4), 5 (Infections
including antibiotics chapters 5:1:1 to 5:1:13), 6 (Endocrine
system) and 9 (Nutrition and blood) that were prescribed dur-
ing the periconceptional period, where maternal consent had
been given, using the participant’s unique Health and Social
Care number. The timing of prescription during (or before)
pregnancy was estimated using the LMP recorded in the ma-
ternity records for cases and controls.
Paediatric cardiology records
Paediatric cardiology records were accessed for type of CHD
and age at diagnosis.
Area-based data
An area based deprivation index was linked according to post-
code of residence of the mother in the first three months of
pregnancy [19]. In future, other area based data can be linked,
including air pollution data.
Sample size
The sample size target (80% power, significance level 5%)
was 400 CHD cases, with ratio of 2 controls to 1 case, to
detect Odds Ratios between 1.5 and 2 for common exposures
of 10% to 25% prevalence in the pregnant population as pre-
dicted for the main exposures of interest. We recognised that
sample power for specific CHD subgroups would be limited.
Our achieved sample size was over the target for controls, and
under the target for cases (Figure 1a). For controls, extra
recruitment was due to dropping of the requirement for all
women to have received the information leaflets at booking,
while preserving the monthly recruitment plan (Figure 1b).
For cases, we overestimated the participation rate and under-
estimated the proportion who would be diagnosed at over 1
month of age, curtailing recruitment of later births.
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Statistical Analysis
Potential recruitment and recall bias was assessed with the
chi square test comparing controls and the general popula-
tion, and comparing controls and cases. Fisher’s exact test
was used where one or more cell sizes were below 5. Differ-
ences in the number of missing question responses per woman
were examined using the Wilcoxon rank-sum (Mann-Whitney)
test. Analysis was carried out using STATA version 12.
Ethics and governance
Ethics approval was obtained from the Office for Research
Ethics Committees Northern Ireland. Research and Gover-
nance approval was obtained from each Trust. Signed in-
formed consent was obtained from all women.
Results
Recruitment rates
The final sample size was 286 cases and 966 controls. Sixty-
one percent of eligible cases and 68% of eligible controls were
recruited (Figures 1a & 1b ). The refusal rate was low for
both groups (8% cases, 8% controls). Non-return of postal
questionnaires accounted for 9% of eligible cases, and 13%
of eligible controls. Other reasons for non-participation were
mostly logistical (Figures 1a & 1b ). Twelve controls trans-
ferred to case status, slightly more than the number expected
to do so (expectation was 8 per 1,000 * 978 = 8). Most com-
pleted the questionnaire using the iPad (cases: 77%; controls:
90 %).
The most common categories of CHD were Ventricular
Septal Defects (28%);anomalies of the extrapericardial arterial
trunks (including coarctation of the aorta) (26%); and anoma-
lies of the ventricular outflow tracts which include Tetralogy
of Fallot and Transposition of the Great Arteries (15%).
Demographic and periconceptional character-
istics and potential for recruitment bias
Of the key sociodemographic and exposure characteristics of
controls, the only significant difference compared with the gen-
eral population was country of birth of mother, with less study
women born outside the United Kingdom (UK) UK/Ireland
(7% vs 10%, Table 1). Cases and controls were comparable
except for a tendency for cases to be less educated (P=0.009,
Table 1). Comparing controls who completed questionnaires
by iPad or on paper (data not shown), sociodemographic char-
acteristics were comparable, except that those from rural ar-
eas were more represented among iPad completers (37.9%
vs 22.6%, P<0.001) and those born in countries outside the
UK/Ireland were more represented among paper questionnaire
completers (21.7%) than iPad completers (5.4% P<0.001).
Thirty-three percent of mothers responded “I was not plan-
ning to become pregnant”, with no significant difference be-
tween cases and controls (P=0.12, Table 1). Figure 2 shows
the gestational age at which women suspected they were preg-
nant, first saw a health professional, and had a “booking
appointment” with a midwife. By 5 weeks’ gestation, 76%
(n=951) of both cases and controls suspected they were preg-
nant. The curves for both cases and controls are very similar.
Time of diagnosis of CHD and questionnaire
completion.
Twenty-eight percent of cases were diagnosed prenatally, 30%
before they were one month old, and 42% thereafter. Cumu-
latively, 16% of the case sample had completed the question-
naire during the prenatal stage, 20% by 1 month of age, 58%
by 6 months, and 88% by 1 year. The median time between
pregnancy onset (LMP) and survey completion for cases was
56 weeks. Controls completed the questionnaire at a median
of 20 weeks’ gestation (range 18-34 weeks’ gestation).
Permission for data linkage and follow up
Overall a high proportion of the sample gave permission to
access additional medical information (97-98%) and to be fol-
lowed up for future studies (95%). For cases, the mode of
questionnaire completion did not influence the decision to al-
low access to medical records (97-98%). Controls who com-
pleted the paper version of the questionnaire were less likely
than those who completed iPad questionnaire to give permis-
sion for all types of data access (91-92%, P<0.001 for each
type) and for follow up for future studies (73%, P<0.001).
Missing data
The proportion of missing data for the questionnaire for most
items ranged from 0% to 3%. The only exceptions were that
while women reported overall levels of alcohol, responses to
questions about specific drinks and drink sizes were missed for
5-9%.
The total number of missing items per person ranged from
zero (63%) to 56 (0.2%). This did not significantly vary be-
tween cases and controls (z= -1.952, P=0.051) but did vary
by mode of completion with paper completers having a signifi-
cantly higher rate of missing answers (z = -16.327, P<0.001).
Of women who had given consent, we were unable to access
the full maternity data for 0.6% (n=8) of women from mater-
nity records, and 1.6% (n=15) from prescription data.
Data linkage and concordance between
sources of data for medication use and
pregnancy planning
Concordance between data sources was examined for antiasth-
matics, antidepressants and antibiotics. Maternity data re-
ported considerably lower frequencies of exposure for all three
medication types, but a high proportion (76-86%) of mater-
nity reports were confirmed by the self–reported questionnaire
(Table 2). The pattern of concordance between self-report
and prescription data differed according to type of medication.
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Figure 1a: Flow diagram of recruitment for cases
Other non-
recruitment; Not
contactable;
Diagnosed near end
of study
(N=105)
Eligible Case women
(N=469)
Refusal
(N=38)
Completed by iPad
at clinic
(N=205)
Completed by iPad
at home
(N=15)
Posted paper
questionnaire
(N=106)
Non-return
(N=40)
Returned
questionnaire
(N=66)
Final Cases
(N=286)
*N= 469 includes N=12 originally identified as controls
Figure 1b: Flow diagram of recruitment for controls
Missed at clinic
(N=146)
Eligible Control
women
(N=1438)
Refusal
(N=115)
Completed by iPad
at clinic
(N=890)
Took questionnaire
away
(N=287)
Questionnaire Non-
return
(N=189)
Did not return
consent form
(N=10)
Completed
questionnaire and
consent forms
(N=978)
Reclassified as case
(N=12)
Final Controls
(N=966)
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Table 1: Distribution of sample by key demographic variables, and comparison with population information where available.
Cases Controls P value for cases
vs controls
Population(a) P values for controls
vs PopulationN=286 N=966 2014-2015
N % N % P N % P
Age Mother
≤24 45 15.7 158 16.4 P=0.43 4153 17.0 P=0.42
25-29 76 26.6 256 26.5 6619 27.1
30-34 93 32.5 350 32.2 8220 33.7
35+ 72 25.2 202 20.9 5405 22.1
Level of Education
Left after compulsory education completed 78 27.3 193 20.0 P=0.009 - -
Higher secondary school/Technical college 107 37.4 351 36.3 - -
University degree 100 35.0 421 43.6 - -
Missing 1 0.4 1 0.01 - -
Deprivation[19]
Quintile 1 Most deprived 72 25.8 196 20.3 P=0.39 5612 23.4 P=0.45
Quintile 2 55 19.2 200 20.7 5313 22.1
Quintile 3 54 18.9 212 22.0 5155 21.5
Quintile 4 51 17.8 191 19.8 4749 19.8
Quintile 5 Least deprived 41 14.3 147 15.2 3571 14.9
Missing 13 4.6 20 2.1
Area of Residence
Urban 175 61.2 576 59.6 P=0.75 - -
Rural 98 34.3 352 36.4 - -
Missing 13 4.6 38 3.9 - -
Country of birth of mother
Northern Ireland 233 81.5 791 81.9 P=0.64 20129 82.5 P=0.02
Other UK/Ireland 17 6.0 74 7.7 1799 7.4
All other countries 20 7.1 64 6.6 2469 10.2
Missing 16 5.6 37 3.8 0 0.0
Smoking at Booking
Yes (1+) 40 14.0 109 11.3 P=0.12 3500 14.5 P=0.06
Missing 37 12.9 78 8.1 - -
Planned pregnancy (self-report)
Yes 176 61.5 642 66.5 P=0.12 - -
No 109 38.1 320 33.1 - -
Missing 1 0.4 4 0.4 - -
Maternal BMI at booking
Underweight (<18.50) 5 1.75 11 1.2 P=0.93 479 2.0 P=0.17
Normal (18.50-24.99) 130 45.5 458 47.3 11613 48.6
Pre-obese (25.00-29.99) 81 28.3 274 28.4 7026 29.6
Obese I (30.00-34.99) 38 13.3 116 12.0 2954 12.4
Obese II (35.00-39.99) 13 4.6 51 5.3 1221 5.1
Obese III (>=40.00) 9 3.2 33 3.4 579 2.4
Missing 10 3.5 23 2.4 313 1.3
(a)Public Health Agency. Children’s Health in Northern Ireland. [Internet]. 2016. Available from:
http://www.publichealth.hscni.net/sites/default/files/RUAG report 2015-16 - Children’s Health in NI - FINAL REPORT - May
2016.pdf (Notes:1.This report uses birth from a range of sources resulting in differences in totals; 2.Births reported are for one
year in total distributed over 2 calendar years. See report for full details)
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Figure 2: Cumulative frequency of gestational age when pregnancy first suspected, at first contact with a Health Care Professional
(HCP) about the pregnancy, and at booking appointment with midwife, for cases and controls.
Note: Co = Controls; Ca = Cases
For antidepressants, 84% of self-reported exposures were con-
firmed by postconceptional prescription among controls, rising
to 91% when considering prescriptions in the periconceptional
period (Table 2). The remaining discordance is explained by
women self-reporting diazepam as an antidepressant which was
not included in the SSRI/SNRI-based prescription measure.
For antibiotics and antiasthmatics, the confirmation rates were
lower (Table 2), but increased somewhat if periconceptional
prescriptions were considered. There were no statistically sig-
nificant differences between cases and controls (p>0.05 for all
comparisons).
Postconception (first three months) prescription data re-
ported higher numbers of women receiving prescriptions than
self-reported exposure for antidepressants and antibiotics, but
lower for antiasthmatics. Proportions of postconceptional
prescriptions which were confirmed by self-reported exposure
among controls varied between 44% for antibiotics and 72%
for antiasthmatics, with no significant differences between
cases and controls. Agreement was lower if periconceptional
prescriptions were considered. Agreement was high between
maternity data and self-report as to whether folic acid had
been started preconceptionally (Table 2). However, the pro-
portion of women whose maternity report of folic acid was con-
firmed by self-report was significantly higher for controls (84%)
than cases (73%, p=0.03). Women were more likely to have
self-reported that they had not planned to become pregnant
than was recorded in the maternity data (Table 2), but ma-
ternity data was generally confirmed by self-report, and there
were no significant differences in proportion between cases and
controls.
Discussion
General considerations
We have developed a methodology and tools which could be
a useful basis for other studies and eventual meta-analysis, as
there is a huge need for more epidemiological evidence about
the environmental causes of congenital anomalies, and particu-
larly congenital heart disease, as a basis for primary prevention
[20]. Our experience suggests that a hybrid means of data col-
lection, employing technologies such as iPad for self-reported
data, with linkage to electronic healthcare databases for in-
formation collected (prospectively) by health professionals is
a promising way forward. Linkage to health records means
that information to be gained by self-report can be kept to a
minimum of information not recorded in health records (such
as education, over the counter medication and prepregnancy
lifestyle factors), thus reducing responder burden and improv-
ing participation. Linking prospectively collected information
also means that the potential for maternal recall bias in case-
control studies can be diminished, or its extent estimated. The
final hybrid dataset becomes a very rich dataset.
We found high levels of permission for record linkage. How-
ever, controls who had chosen to take the paper questionnaire
for postal return were a little less likely to give permission
for record linkage, perhaps because they were in general less
keen on participation, or less contact with the researcher gen-
erated less trust, or consultation with family members who
had not met with the researcher led to lower levels of trust.
This suggests that permission is context dependent, which is
important to take into account in planning hybrid data link-
age research. Our control population was a representative
sample of the Northern Ireland population as judged by key
sociodemographic characteristics, except for the slightly lower
7
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Table 2: Agreement between self-report data (questionnaire) and administrative data (maternity data and prescription records) for
medication use, preconception folic acid supplements, and unplanned pregnancy.
Type of
Exposure
Control/Case Number exposed to medication as
reported by three data sources
Proportion of exposure reports of one data source
confirmed by another source.
Self-
report
- taken
in first
trimester
Maternity
data -
reported
at 10-12
weeks
gestation
Prescription
data -
post con-
ception
(pericon-
ception)
Self-
report
confirmed
by ma-
ternity
data
maternity
data con-
firmed
by self-
report
Self-
report
confirmed
by pre-
scription
post con-
ception
(peri-
conception)
Post con-
ception
(pericon-
ception)
prescrip-
tion con-
firmed by
self-report
N N N % % % %
Antidepressants Controls 32 21 50 (68) 50.0 76.2 84.4 (90.6) 54.0 (42.6)Cases 7 4 16 (25) 42.9 75.0 71.4 (100.0) 31.3 (28.0)
Antibiotics Controls 105 13 140 (222) 10.5 84.6 59.0 (67.6) 44.3 (32.0)Cases 27 4 36 (55) 3.7 25.0 48.1 (55.6) 36.1 (27.3)
Antiasthmatics Controls 58 28 43 (64) 41.4 85.7 53.4 (75.9) 72.1 (68.8)Cases 13 8 13 (19) 46.2 75.0 61.5 (84.6) 61.5 (57.9)
Preconception Controls 347 337 - 81.3 83.7 - -
Folic acid Cases 86 92 - 79.1 73.9 - -
Unplanned Controls 301 227 - 70.4 93.4 - -
pregnancy Cases 94 66 - 63.8 90.9 - -
Note: Pre-conception: three months before pregnancy; Postconception: first three months of pregnancy; Periconception: three
months before and first three months of pregnancy
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participation of those born outside UK/Ireland (partly by de-
sign due to budget limitations for language translation). We
are therefore able to use the information gathered to analyse
the health conditions of the pregnant population in Northern
Ireland, adding to the cost-effectiveness of the study.
One third of mothers reported that they had not planned to
become pregnant (a slightly higher proportion than estimated
from maternity records), and one quarter had not suspected
they were pregnant before 6 weeks gestation. To our knowl-
edge, these are the first population-based reports of the timing
of pregnancy recognition, and these data enable us to inves-
tigate in the control population timing of health behaviour
change and change after contact with a health professional.
Since the major development of the fetal heart occurs when
women may not know they are pregnant, these results also con-
firm the importance of asking about women’s usual prepreg-
nancy exposures as well as change during the first trimester
when studying the aetiology of congenital heart disease, and
planning public health interventions to prevent birth defects.
Recruitment and recruitment bias
Although there have been concerns about the low levels of
recruitment currently achieved in perinatal studies, we found
our recruitment strategy for control women to be successful:
recruitment by a researcher within the maternity environment,
a designated month for recruitment per unit (rather than con-
tinuous sampling across the entire population), use of an iPad
to increase ease and enjoyment of participation, having a short
questionnaire and an attractive information leaflet, and offer
of a small incentive/token of gratitude. Postal questionnaires
were poorly returned, and phone contact with women tended
to be difficult to establish. We did not test the option of
web-based [21,22] or App questionnaires to complete at home,
however our experience suggests completion at time of recruit-
ment leads to higher response. The rate of refusal was low.
Most non-recruitment was for logistical reasons and the final
sample remained representative of the Northern Ireland preg-
nant population.
Comparison of sociodemographic characteristics between
cases and controls revealed little indication of potential selec-
tion bias, except in relation to maternal education, which may
be a risk factor for congenital heart disease. Anecdotally, we
were aware of a few mothers with eligible cases who did not
want to participate due to feelings of potential guilt an issue
that has not been addressed in the methodological literature
which tends to focus on maternal recall bias.
Contrary to our expectations, the recruitment of cases
proved more difficult than recruitment of controls, due to the
logistical difficulties of meeting women at their hospital ap-
pointments, and poor return of postal questionnaires. We
found the investment of the researchers time in home visits
in the later part of the study was not disproportionate com-
pared to trying to meet mothers at clinics, and in future, we
would recommend this method of recruitment. We recruited
less cases prenatally, and less in the early neonatal period, than
we had expected. The US National Birth Defect Prevention
Study has also noted late recruitment of cases [23] and this is
a key problem in case-control studies of congenital anomalies
[24] especially of congenital heart disease where many diag-
noses are made after the neonatal period. Although matching
controls to cases by age at recruitment would be theoretically
less prone to information bias, we had no access as researchers
to a suitable population-based sampling frame to achieve this,
nor a recruitment context for controls similar to the mater-
nity unit opportunity. The key concern then is whether there
is evidence of information bias relating to maternal recall to
outweigh the advantages of our recruitment method.
Assessment of recall bias
Recall bias, where mothers of cases with congenital anoma-
lies are more motivated to recall exposures than mothers of
controls, has been much discussed in the literature, with as-
sessments varying as to its possible strength, and possible ways
to mitigate it [25,26]. In our study, there is an additional recall
bias issue - the longer period of recall for cases than controls
leading to potential poorer recall by case mothers. Case moth-
ers were much further beyond their early pregnancy exposures
than controls, and had experienced much in between with the
birth of a baby with CHD. The iPad was a useful tool on
which to establish, display and reinforce the early pregnancy
time window to aid recall. We found remarkable similarity be-
tween cases and controls in the curves of when women recalled
that they had become aware of their pregnancy and sought
health professional advice, reinforcing confidence in the recall
of key events. In general, levels of concordance between re-
called medication exposures and medical records were slightly
lower for cases, which might suggest slightly poorer recall of
exposure or exposure timing over the longer recall period, or a
tendency for cases to over-report, but this was not statistically
significant. The only significant difference was that maternity
reports of folic acid intake were less likely to be confirmed by
the self-report of cases than controls, consistent with the ef-
fect of a longer recall period or over-reporting by cases. Lack
of evidence of systematic recall bias leads us to conclude that
comparability of timing of interview of cases and controls was
worth sacrificing to gain high recruitment and representative
population samples. Nevertheless, the potential for some re-
call bias needs to be taken into account in the interpretation
of results.
Concordance of self-report, maternity data
and prescription data
There is no gold standard for measuring medication exposure
in pregnancy, yet the issue of medication safety in pregnancy
is extremely important and under-researched [27]. Our data
shed light on the advantages and disadvantages of different
data sources, showing this to be dependent on medication
type. The maternity database (NIMATS) was a poor source
of data, with low sensitivity for exposures compared to self-
report, for all medication types. This is probably because the
maternity database system only asks at the time of the book-
ing appointment about current medication intake. The par-
ticularly low sensitivity for antibiotics as opposed to chronic
disease medications reflects this. We concluded that maternity
data, for our study, had little extra value, and that if mater-
nity databases are to become an important source of data for
pregnancy-related medication safety studies, more emphasis is
needed on recording early pregnancy exposures.
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For antidepressants, retrospective self-report was very
likely to be confirmed by prescription data. The proportion
of postconceptional prescriptions confirmed by self-report was
however not high. The potential reasons for a woman not self-
reporting antidepressant exposure where the postconceptional
prescription data suggests it has been prescribed include the
woman not taking the medication because it is her first pre-
scription and she decides not to, the woman not taking the
medication because she is concerned about its safety in preg-
nancy, the woman obtaining the medication for others (known
to occur with antidepressants in our population), poor recall
about exposures prior to pregnancy recognition, or reluctance
to declare exposure. We concluded that self-report was the
best primary measure of exposure, with secondary sensitivity
analysis using postconceptional prescription data to explore
potential for recall bias.
The situation regarding antiasthmatics (which are all
prescription-only in Northern Ireland) is different – women are
advised not to discontinue antiasthmatics in pregnancy [28],
and many antiasthmatics are taken on an intermittent rather
than chronic basis. This means that prescription dates are
a poorer guide to timing at use [29], but also that recall of
exact timing of use in relation to recognition of pregnancy
may be more difficult. The proportion of self-reported an-
tiasthmatics confirmed by periconceptional prescriptions was
lower for antiasthmatics than for antidepressants, probably in-
dicating that some prescriptions had been obtained before the
periconceptional period. On the other hand, compared to an-
tidepressants, prescriptions were more likely to be confirmed
by self-report, probably reflecting the fact that women did not
stop using antiasthmatics that they had been prescribed [28].
We concluded again that self-report is the most appropriate
primary measure, with prescription data a secondary measure
less accurately describing first trimester exposure, but guard-
ing against recall bias.
Acute use of medications such as antibiotics present a dif-
ferent problem. Here we saw the greatest discordance between
self-report and prescription data, probably reflecting both dif-
ficulties recalling short exposures and exact timing, as well as
population behaviour where antibiotics are picked up from the
pharmacy (prescriptions in Northern Ireland are free) but not
necessarily used, or antibiotics are not used at the time of pre-
scription, or there is reluctance to use in pregnancy despite
medical advice. In a study in the Netherlands [30], 82% of
interviewed women who were prescribed antibiotics in the first
trimester took their medicine, but it is not clear if the same
applies to the Northern Ireland population. We concluded
that in the absence of a reliable measure, both self-reported
exposure confirmed by prescription, and postconceptional pre-
scriptions could be analysed as alternative measures. Our data
show that for medication safety studies, research is needed to
understand the medication-taking behaviour of the pregnant
population to inform exposure measurement.
Conclusion
The strengths of the Baby Hearts Case Control study are its
population-based representative sample via a novel sampling
method, diagnostic accuracy regarding CHD through direct
access to medical notes, and hybrid data collection of retro-
spective maternal interview and linkage with (prospective) ma-
ternity, prescription and other records to improve the richness
and validity of data. A further strength is that it can address
questions about the aetiology of CHD, as well as about the
health-related behaviours of a representative sample of preg-
nant women. The main limitation of our study in Northern
Ireland is the smaller than intended achieved sample size for
cases, but we believe there is potential for better recruitment
in future. Our iPad App will be available for use by others,
and we hope that in future similar studies can be conducted
and co-ordinated for meta-analysis.
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